January 21, 2021

Eli Lilly Says Its Monoclonal Antibody Prevented Covid-19 Infections In Clinical Trial-STAT

Eli Lilly said Thursday that its monoclonal antibody prevented Covid-19 infections in nursing home residents and staff in a clinical trial, the first time such a treatment has been shown to prevent infection. Lilly released the results in a press release, although it said that it would publish the data in a research paper as quickly as possible. STAT, 01/21/2021